Work

Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitors

Year: 1999

Type: article

Source: Bioorganic & Medicinal Chemistry Letters

DOI: 10.1016/s0960-894x(99)00104-3

Authors: George D. Hartman, Mark E. Duggan, William F. Hoffman, Robert J. Meissner, James J. Perkins, Amy E. Zartman, Adel M. Naylor-Olsen, Jacquelynn J. Cook, Joan D. Glass, Robert J. Lynch, Guixiang Zhang, Robert J. Gould

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Cell Adhesion Molecules Research

Subfield: Immunology and Allergy

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2067166817

FWCI: 0.726

Cites: 29

Cited by: 7

Related to: 10